| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/31/2008 | WO2008013543A1 Protein probe compounds, compositions, and methods |
| 01/31/2008 | WO2008013530A1 Method for the direct detection and quantitation of asparagine synthetase in biological samples |
| 01/31/2008 | WO2008013324A1 Use of diabetes-related, liver-derived secreted protein in diagnosis or treatment of type-2 diabetes or vascular disorder |
| 01/31/2008 | WO2008013270A1 Method for diagnosis of neuropsychiatric disease |
| 01/31/2008 | WO2008013260A1 Biological specimen and method for preparing the same |
| 01/31/2008 | WO2008012944A1 Method of measuring anticoagulation and reagent for measuring anticoagulation |
| 01/31/2008 | WO2008012941A1 Method for diagnosis of heart failure |
| 01/31/2008 | WO2008012932A1 Insulin resistance reducer |
| 01/31/2008 | WO2008012703A1 Radiation detectors using evanescent field excitation |
| 01/31/2008 | WO2008012650A2 An immunochromatography device for the diagnosis of diseases in a sample |
| 01/31/2008 | WO2008012642A2 Process for determining s-nitrosothiols in biological fluids |
| 01/31/2008 | WO2008012552A1 Formation of bilayers of amphipathic molecules |
| 01/31/2008 | WO2008012503A1 Homologue of pro4426 |
| 01/31/2008 | WO2008012391A1 Method for the surface treatment of solid substrates |
| 01/31/2008 | WO2008012362A2 New protein isoforms and uses thereof |
| 01/31/2008 | WO2008012197A1 Electrochemical system for assaying a biological compound by an enzyme |
| 01/31/2008 | WO2008012101A1 METHOD FOR THE DETECTION OF AMYLOID-β OLIGOMERS IN BODY FLUIDS |
| 01/31/2008 | WO2008012093A2 Method and arrangement for determining the yarn quality and/or spool quality of a running thread based on laser-doppler anemometry |
| 01/31/2008 | WO2008012049A1 Post-translationally modified neurotrophins |
| 01/31/2008 | WO2008012044A1 Determination of the biological activity of heparin in at iii-containing preparations |
| 01/31/2008 | WO2008012019A2 Method for controlling the therapy of patients suffering from cardiac insufficiency by means of in vitro determination of threshold values of vasoactive peptides |
| 01/31/2008 | WO2008011972A1 Device and method for detecting articles with pipette and nanopore |
| 01/31/2008 | WO2008011928A1 Chitosan as a colour-fixing agent |
| 01/31/2008 | WO2008011927A2 Urinary immunochromatographic antigen detection cup |
| 01/31/2008 | WO2008011926A1 Saliva immunochromatographic detection cup |
| 01/31/2008 | WO2008011925A1 Urinary immunochromatographic detection cup |
| 01/31/2008 | WO2008011876A2 Arrangement for on-line measurements on cells |
| 01/31/2008 | WO2008011812A1 Biomimetic cell membrane of phospholipid polymer, preparation method and use thereof |
| 01/31/2008 | WO2008011713A1 Methods of diagnosis and treatment for metabolic disorders |
| 01/31/2008 | WO2008011711A1 Cancerous disease modifying antibodies |
| 01/31/2008 | WO2008011710A1 Cytotoxicity mediation of cells evidencing surface expression of cd63 |
| 01/31/2008 | WO2008011709A1 Biomarkers for use in the diagnosis and treatment of colorectal cancer |
| 01/31/2008 | WO2007149136A3 Immunoassay magnetic trapping device |
| 01/31/2008 | WO2007140962A3 Improved measurement of vitamin d |
| 01/31/2008 | WO2007127464A3 Methods and compounds to modulate parvovirus transduction of mammalian cells or to alter virus infection, method to identify a viral receptor or co-receptor |
| 01/31/2008 | WO2007116324A3 Consumer food testing device |
| 01/31/2008 | WO2007114896A3 Prognostic and diagnostic method for cancer therapy |
| 01/31/2008 | WO2007110779A8 Assay device and method |
| 01/31/2008 | WO2007108779A8 Microfluidic device for analyzing the status of a particle |
| 01/31/2008 | WO2007106224A3 Method of detecting or diagnosing of a neurodegenerative disease or condition |
| 01/31/2008 | WO2007087013B1 Functional immunoassay |
| 01/31/2008 | WO2007079141A3 Method of identifying compounds useful to treat neuronal degenerative diseases |
| 01/31/2008 | WO2007053654A3 Agglutination-based method for fast detection, isolation and quantification of apoptotic cells |
| 01/31/2008 | WO2007053165A3 Virus protein microarray and uses therefor |
| 01/31/2008 | WO2007038792A8 Individualized cancer treatments |
| 01/31/2008 | WO2006096735A8 Enhancing a luminescent signal |
| 01/31/2008 | WO2006041959A8 Detection of elevated levels of her-2/neu protein on circulating cancer cells and treatment |
| 01/31/2008 | US20080027297 Non-invasive blood constituent measuring instrument and measuring method |
| 01/31/2008 | US20080027217 Method to Obtain Purified Human Genomic Nucleic Acid |
| 01/31/2008 | US20080027213 Chimeric immunogens |
| 01/31/2008 | US20080027148 Drug targets related to synthase subfamily; alternative splice forms; isolated peptides and antibodies |
| 01/31/2008 | US20080027147 polypeptides for use in the diagnosis and treatment of cell proliferative disorders |
| 01/31/2008 | US20080027146 Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases |
| 01/31/2008 | US20080027145 Therapeutic Molecules and Methods for Generating and/or Selecting Same |
| 01/31/2008 | US20080027115 Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof |
| 01/31/2008 | US20080027106 Methods of treating psychosis and schizphrenia based on polymorphisms in the cntf gene |
| 01/31/2008 | US20080027096 Novel Pharmaceutical Compositions |
| 01/31/2008 | US20080027095 Use Of 3-Substituted-2-(Diphenylmethy)-1-Azabicyclo[2.2.2]Octanes For Treating Mrg-X1 Receptor Mediated Diseases |
| 01/31/2008 | US20080027047 Compounds that modulate HSP90 activity and methods for identifying same |
| 01/31/2008 | US20080027004 Phosphorylated COP1 molecules and uses thereof |
| 01/31/2008 | US20080027002 Compositions and methods for targeting cancer-specific transcription complexes |
| 01/31/2008 | US20080027001 Nogo receptor functional motifs, peptide mimetics, and mutated functional motifs related thereto, and methods of using the same |
| 01/31/2008 | US20080026995 Therapeutic vaccine targeted against p-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers |
| 01/31/2008 | US20080026992 Tyrosine Phosphorylation of Cdk Inhibitor Proteins of the Cip/Kip Family |
| 01/31/2008 | US20080026989 Human Ependymin |
| 01/31/2008 | US20080026950 Gene Relating to Estimation of Postoperative Prognosis for Breast Cancer |
| 01/31/2008 | US20080026948 Protein (poly)peptides libraries |
| 01/31/2008 | US20080026486 Assay Methods, Materials and Preparations |
| 01/31/2008 | US20080026485 Antibody profiling for determination of patient responsiveness |
| 01/31/2008 | US20080026482 detrmining organic carbon content and/or nitrogen in water; aqueous sample is evaporated and combusted in heating vessel equipped with a heating facility and the combustion product is fed in a transport gas flow to a detector for determination of the concentration of a gaseous compounds |
| 01/31/2008 | US20080026481 Molecular based two-marker assays that predict outcome of adenocarcinoma patients |
| 01/31/2008 | US20080026480 Detection systems for mass labels |
| 01/31/2008 | US20080026479 Peptide derivatization method to increase fragmentation information from MS/MS spectra |
| 01/31/2008 | US20080026478 providing a dye 2-[(E)-2-(8-Dihexylamino-2-hydroxy-4,5-dioxo-4H,5H-pyrano[3,2-c]chromen-3-yl)-vinyl]-3,3-dimethyl-5-sulfo-1-(3-sulfo-propyl)-3H-indolium sodium salt or it's chelate compound and a biocompatible excipient to stain the protein by forming protein-dye complex |
| 01/31/2008 | US20080026477 Method for preparing polymeric organic iridium compositions |
| 01/31/2008 | US20080026476 Device and Method for Detecting Blood Coagulation |
| 01/31/2008 | US20080026475 using flow cytometry; sphering of erythrocytes in such a way that they can be detected by a cytometer or an automatic counting device; using reagents containing amines in the presence of a carbamate and/or of a catalyst of the reaction; rapid and more complete action |
| 01/31/2008 | US20080026474 Assay for differentiating compounds that modulate the extrinsic and/or intrinsic coagulation pathways |
| 01/31/2008 | US20080026473 Analyte sensors and methods for making and using them |
| 01/31/2008 | US20080026471 sample is heated in an oxidizing atmosphere, its temperature being successively raised to a first, then to a second value; first value below 200 degrees C. being reached very quickly, then maintained substantially constant for a certain time, second value ranging between 600 degrees C. and 850 degrees C. |
| 01/31/2008 | US20080026470 Device and Method for Determining the Content of Phenolic Components in Must and Wine |
| 01/31/2008 | US20080026469 Method for the Detection of Phosphine in Cereals |
| 01/31/2008 | US20080026468 Preparation of a red blood cell component for a hematology control |
| 01/31/2008 | US20080026454 Biomolecule diagnostic devices and method for producing biomolecule diagnostic devices |
| 01/31/2008 | US20080026452 Device for Determining Distribution of Glycation of Erythrocytic Membranes |
| 01/31/2008 | US20080026447 Assay for determining factor viia inhibitor concentration in plasma samples |
| 01/31/2008 | US20080026427 HUMAN cDNAs AND PROTEINS AND USES THEREOF |
| 01/31/2008 | US20080026423 DEP-1 receptor protein tyrosine phosphatase interacting proteins and related methods |
| 01/31/2008 | US20080026420 Systems and methods for automated analysis of cells and tissues |
| 01/31/2008 | US20080026417 Assays for trichomonal and other hydrolases |
| 01/31/2008 | US20080026414 Method for the Determination of the Formation of Endothelins for Medical Diagnostic Purposes, and Antibodies and Kits for Carrying Out Such a Method |
| 01/31/2008 | US20080026413 Complexes and methods |
| 01/31/2008 | US20080026412 Beta-2 microglobulin as a biomarker for peripheral artery disease |
| 01/31/2008 | US20080026411 Diagnostic and prognostic methods and compositions of matter for cell proliferative diseases |
| 01/31/2008 | US20080026410 Biomarkers for Bladder Cancer |
| 01/31/2008 | US20080026409 Salt-sensitive hypertension |
| 01/31/2008 | US20080026408 Isolation of analytes |
| 01/31/2008 | US20080026407 Covalent tethering of functional groups to proteins |
| 01/31/2008 | US20080026406 Method For Diagnosis Of Myelodysplastic Syndromes (Mds) |
| 01/31/2008 | US20080026405 Biomarkers of mild cognitive impairment and alzheimer's disease |